ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported financial results for the third quarter ended September 30, 2025, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback